The New York Fertility Center – FDA 483, Feb 27, 2019
The New York Fertility Center in Flushing, NY, received a Form 483 with four observations related to deficiencies in donor eligibility determination and communicable disease testing for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). The firm failed to adequately test donors for relevant communicable diseases like West Nile Virus, screen for Zika Virus risk factors, and properly document testing procedures and laboratory certifications. These issues indicate significant concerns regarding the safety and quality of HCT/Ps.
ID · e73da565-d29c-4d78-b38b-ee48dd5ed358
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.